Source-supplied identity
Client details
- Exact LDA ID
- 52396
- State
- MD
- Country
- US
- Source client ID
- 52396
Experience in developing and commercializing products that treat central nervous system
Exact source ID relationship
Recent filings
- SUPERNUS PHARMACEUTICALS INCJEFFREY J. KIMBELL & ASSOCIATES, INC. · 2nd Quarter (Apr 1 - June 30) 2026
- SUPERNUS PHARMACEUTICALS INCJEFFREY J. KIMBELL & ASSOCIATES, INC. · 1st Quarter (Jan 1 - Mar 31) 2026
- SUPERNUS PHARMACEUTICALS INCJEFFREY J. KIMBELL & ASSOCIATES, INC. · 4th Quarter (Oct 1 - Dec 31) 2025
- SUPERNUS PHARMACEUTICALS INCJEFFREY J. KIMBELL & ASSOCIATES, INC. · 3rd Quarter (July 1 - Sep 30) 2025
- SUPERNUS PHARMACEUTICALS INCJEFFREY J. KIMBELL & ASSOCIATES, INC. · 2nd Quarter (Apr 1 - June 30) 2025
- SUPERNUS PHARMACEUTICALS INCJEFFREY J. KIMBELL & ASSOCIATES, INC. · 1st Quarter (Jan 1 - Mar 31) 2025
Identity boundary
This page groups filings only by the exact numeric identifier supplied by the LDA API. Politically.com does not merge similar names or infer organizational relationships.